$VMD

VIEMED HEALTHCARE, INC.

CIK:0001729149|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 78,097	$ 63,056	$ 153,511	$ 122,185
Cost of revenue	33,049	26,325	65,636	52,175
Gross profit	45,048	36,731	87,875	70,010
Operating expenses
Selling, general and administrative	37,132	28,803	71,924	57,228
Research and development	504	847	1,083	1,644
Stock-based compensation	2,032	2,341	4,483	4,652
Depreciation and amortization	388	353	776	701
Loss (gain) on disposal of property and equipment	598	(636)	954	(3,004)
Other income, net	(67)	(72)	(102)	(147)
Income from operations	4,461	5,095	8,757	8,936
Non-operating income and expenses
Loss from other investments	162	0	162	0
Interest expense, net	248	132	553	311
Net income before taxes	4,051	4,963	8,042	8,625
Provision for income taxes	1,151	1,713	2,429	2,665
Net income	2,900	3,250	5,613	5,960
Net income attributable to noncontrolling interest	136	93	267	178
Net income attributable to Viemed Healthcare, Inc.	$ 2,764	$ 3,157	$ 5,346	$ 5,782
Net income per share
Basic (in USD per share)	$ 0.07	$ 0.08	$ 0.14	$ 0.15
Diluted (in USD per share)	$ 0.07	$ 0.08	$ 0.13	$ 0.14
Weighted average number of common shares outstanding:
Basic (in shares)	38,245,491	39,515,247	38,336,534	39,471,244
Diluted (in shares)	41,125,716	41,083,760	40,851,506	41,393,523

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net income	$ 5,613	$ 5,960
Adjustments for:
Depreciation and amortization	15,141	13,504
Stock-based compensation expense	4,483	4,652
Loss (gain) on disposal of property and equipment	954	(3,004)
Amortization of deferred financing costs	132	64
Deferred income tax benefit	0	(1,961)
Loss from other investments	162	0
Changes in working capital:
Accounts receivable, net	(6,643)	(1,638)
Inventory	(221)	(4)
Prepaid expenses and other assets	(1,665)	(150)
Trade payables	2,072	1,598
Deferred revenue	483	499
Accrued liabilities	1,405	(1,979)
Income tax payable/receivable	2,057	(2,433)
Net cash provided by operating activities	23,973	15,108
Cash flows from investing activities
Purchase of property and equipment	(15,172)	(23,612)
Investment in equity investments	(552)	0
Proceeds from sale of property and equipment	2,401	13,355
Net cash used in investing activities	(13,323)	(10,257)
Cash flows from financing activities
Proceeds from exercise of options	1,057	1,368
Principal payments on term notes	(5,422)	(220)
Shares redeemed to pay income tax	(2,038)	(1,631)
Payments for share repurchase programs	(6,761)	(1,664)
Repayments of finance lease liabilities	0	(35)
Distributions to non-controlling interest	(307)	(193)
Net cash used in financing activities	(13,471)	(2,375)
Net increase (decrease) in cash and cash equivalents	(2,821)	2,476
Cash and cash equivalents at beginning of year	13,501	17,540
Cash and cash equivalents at end of period	10,680	20,016
Supplemental disclosures of cash flow information
Cash paid during the period for interest	390	212
Cash paid during the period for income taxes, net of refunds	373	7,059
Supplemental disclosures of non-cash transactions
Equipment and other fixed asset purchases payable at end of period	4,802	3,955
Equipment sales receivable at end of period	0	986
Repurchases of shares not yet settled	$ 0	$ 169

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 10,680	$ 13,501
Accounts receivable, net	32,229	25,586
Inventory	5,268	5,047
Income tax receivable	0	227
Prepaid expenses and other assets	5,788	4,132
Total current assets	53,965	48,493
Long-term assets
Property and equipment, net	77,159	78,775
Operating lease right-of-use assets	4,531	3,580
Equity investments	3,184	2,794
Deferred tax asset	5,289	5,289
Identifiable intangibles, net	1,158	1,285
Goodwill	58,938	58,938
Total long-term assets	150,259	150,661
TOTAL ASSETS	204,224	199,154
Current liabilities
Trade payables	10,986	7,333
Deferred revenue	8,003	7,520
Income taxes payable	1,830	0
Accrued liabilities	24,941	23,910
Operating lease liabilities, current portion	1,416	1,203
Current portion of long-term debt	717	1,090
Total current liabilities	47,893	41,056
Long-term liabilities
Accrued liabilities	900	922
Operating lease liabilities, less current portion	3,093	2,364
Long-term debt	6,374	11,291
Total long-term liabilities	10,367	14,577
TOTAL LIABILITIES	58,260	55,633
Commitments and Contingencies	0	0
SHAREHOLDERS' EQUITY
Common stock - No par value: unlimited authorized; 38,088,228 and 38,019,082 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	17,981	16,912
Additional paid-in capital	17,810	21,742
Retained earnings	108,237	102,891
TOTAL VIEMED HEALTHCARE, INC.'S SHAREHOLDERS' EQUITY	144,028	141,545
Noncontrolling interest in subsidiary	1,936	1,976
TOTAL SHAREHOLDERS' EQUITY	145,964	143,521
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 204,224	$ 199,154